We've found
20,707
archived clinical trials in
Gastrointestinal
We've found
20,707
archived clinical trials in
Gastrointestinal
A Retrospective Study With Prospective Follow-Up of Laparoscopic Ventral Hernia Repair Utilizing the Bard Sepramesh IP Composite
A Single Arm, Single-Center, Retrospective Study With Prospective Follow-Up of Laparoscopic Ventral Hernia Repair Utilizing the Bard Sepramesh IP Composite
Status: Archived
A Retrospective Study With Prospective Follow-Up of Laparoscopic Ventral Hernia Repair Utilizing the Bard Sepramesh IP Composite
Updated: 1/1/1970
A Single Arm, Single-Center, Retrospective Study With Prospective Follow-Up of Laparoscopic Ventral Hernia Repair Utilizing the Bard Sepramesh IP Composite
Status: Archived
Updated: 1/1/1970
Defining 31Phosphorous Magnetic Resonance Spectroscopy Characteristics in Patients With Mitochondrial Myopathy
Defining 31Phosphorous Magnetic Resonance Spectroscopy Characteristics of the Vastus Lateralis After Sub-maximal Exercise in Patients With Mitochondrial Myopathy
Status: Archived
Defining 31Phosphorous Magnetic Resonance Spectroscopy Characteristics in Patients With Mitochondrial Myopathy
Updated: 1/1/1970
Defining 31Phosphorous Magnetic Resonance Spectroscopy Characteristics of the Vastus Lateralis After Sub-maximal Exercise in Patients With Mitochondrial Myopathy
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (OPAL)
Updated: 1/1/1970
A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Subjects With Opioid-induced Bowel Dysfunction
Status: Archived
Updated: 1/1/1970